Annals of Oncology

News:

Back to baked potato? Or is it another "laboratory finding"?
Ann Oncol 13: 1163-1164; doi:10.1093/annonc/mdf329
[Extract] [FREE Full Text] [PDF] [Request Permissions]

Editorials:

S. Rao and D. Cunningham

Advanced pancreatic cancer—5 years on
Ann Oncol 13: 1165-1168; doi:10.1093/annonc/mdf313
[Extract] [FREE Full Text] [PDF] [Request Permissions]

M. L. Nasi and M. Castiglione

Cyclooxygenase-2 (COX-2) a new prognostic and predictive factor for ovarian cancer? Are all the criteria fulfilled?
Ann Oncol 13: 1169-1171; doi:10.1093/annonc/mdf312
[Extract] [FREE Full Text] [PDF] [Request Permissions]

Review:

J. van der Zee

Heating the patient: a promising approach?
Ann Oncol 13: 1173-1184; doi:10.1093/annonc/mdf280
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Original articles:

Gastrointestinal tumors:

M. Ducreux, P. Rougier, J.-P. Pignon, J.-Y. Douillard, J.-F. Seitz, R. Bugat, J.-F. Bosset, Y. Merouche, J.-L. Raoul, M. Ychou, A. Adenis, F. Berthault-Cvitkovic, and M. Luboinski

A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinoma
Ann Oncol 13: 1185-1191; doi:10.1093/annonc/mdf197
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

J. Taïeb, E. Mitry, V. Boige, P. Artru, J. Ezenfis, T. Lecomte, M. C. Clavero-Fabri, J. N. Vaillant, P. Rougier, and M. Ducreux

Optimization of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of leucovorin, 5-FU and cisplatin (LV5FU2-P regimen) in patients with biliary tract carcinoma
Ann Oncol 13: 1192-1196; doi:10.1093/annonc/mdf201
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

S. Hegewisch-Becker, Y. Gruber, A. Corovic, U. Pichlmeier, D. Atanackovic, A. Nierhaus, and D. K. Hossfeld

Whole-body hyperthermia (41.8°C) combined with bimonthly oxaliplatin, high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer: a phase II study
Ann Oncol 13: 1197-1204; doi:10.1093/annonc/mdf216
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Gynecologic tumors:

G. Ferrandina, L. Lauriola, G. F. Zannoni, A. Fagotti, F. Fanfani, F. Legge, N. Maggiano, M. Gessi, S. Mancuso, F. O. Ranelletti, and G. Scambia

Increased cyclooxygenase-2 (COX-2) expression is associated with chemotherapy resistance and outcome in ovarian cancer patients
Ann Oncol 13: 1205-1211; doi:10.1093/annonc/mdf207
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

A. Duenas-Gonzalez, C. Lopez-Graniel, A. Gonzalez-Enciso, A. Mohar, L. Rivera, A. Mota, R. Guadarrama, G. Chanona, and J. de la Garza

Concomitant chemoradiation versus neoadjuvant chemotherapy in locally advanced cervical carcinoma: results from two consecutive phase II studies
Ann Oncol 13: 1212-1219; doi:10.1093/annonc/mdf196
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Breast cancer:

K. D. Miller, W. Gradishar, L. Schuchter, J. A. Sparano, M. Cobleigh, N. Robert, H. Rasmussen, and G. W. Sledge

A randomized phase II pilot trial of adjuvant marimastat in patients with early-stage breast cancer
Ann Oncol 13: 1220-1224; doi:10.1093/annonc/mdf199
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

E. A. Perez, L. Geeraerts, V. J. Suman, A. A. Adjei, A. T. Baron, A. K. Hatfield, N. Maihle, J. C. Michalak, S. A. Kuross, J. W. Kugler, J. M. Lafky, and J. N. Ingle

A randomized phase II study of sequential docetaxel and doxorubicin/cyclophosphamide in patients with metastatic breast cancer
Ann Oncol 13: 1225-1235; doi:10.1093/annonc/mdf222
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

H. M. Verkooijen, G. Fioretta, C. de Wolf, G. Vlastos, J. Kurtz, B. Borisch, P. Schäfer, A. Spiliopoulos, A. P. Sappino, R. Renella, B. Pittet, J. Schmid de Gruneck, Y. Wespi, I. Neyroud-Caspar, and C. Bouchardy

Management of women with ductal carcinoma in situ of the breast: a population-based study
Ann Oncol 13: 1236-1245; doi:10.1093/annonc/mdf194
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Head and neck cancer:

C.-F. Hwang, C.-L. Cho, C.-C. Huang, J.-S. Wang, Y.-L. Shih, C.-Y. Su, and H.-W. Chang

Loss of cyclin D1 and p16 expression correlates with local recurrence in nasopharyngeal carcinoma following radiotherapy
Ann Oncol 13: 1246-1251; doi:10.1093/annonc/mdf215
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

R. K. C. Ngan, H. H. Y. Yiu, W. H. Lau, S. Yau, F. Y. Cheung, T. M. Chan, C. H. Kwok, C. Y. Chiu, S. K. Au, W. Foo, C. K. Law, and K. C. Tse

Combination gemcitabine and cisplatin chemotherapy for metastatic or recurrent nasopharyngeal carcinoma: report of a phase II study
Ann Oncol 13: 1252-1258; doi:10.1093/annonc/mdf200
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Urogenital tumors:

G. Batist, F. Patenaude, P. Champagne, D. Croteau, C. Levinton, C. Hariton, B. Escudier, and E. Dupont

Neovastat (Æ-941) in refractory renal cell carcinoma patients: report of a phase II trial with two dose levels
Ann Oncol 13: 1259-1263; doi:10.1093/annonc/mdf195
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Hematologic malignancies:

G. M. Mead, M. R. Sydes, J. Walewski, A. Grigg, C. S. Hatton, P. Norbert, C. Guarnaccia, M. S. Lewis, J. McKendrick, S. P. Stenning, and D. Wright

An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt’s lymphoma: results of United Kingdom Lymphoma Group LY06 study
Ann Oncol 13: 1264-1274; doi:10.1093/annonc/mdf253
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

E. Maartense, S. le Cessie, H. C. Kluin-Nelemans, P. M. Kluin, S. Snijder, P. W. Wijermans, and E. M. Noordijk

Age-related differences among patients with follicular lymphoma and the importance of prognostic scoring systems: analysis from a population-based non-Hodgkin’s lymphoma registry
Ann Oncol 13: 1275-1284; doi:10.1093/annonc/mdf198
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

E. Weidmann, S.-Z. Kim, A. Rost, H. Schuppert, G. Seipelt, D. Hoelzer, and P. S. Mitrou

Bendamustine is effective in relapsed or refractory aggressive non-Hodgkin’s lymphoma
Ann Oncol 13: 1285-1289; doi:10.1093/annonc/mdf189
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

C. Visco, L. J. Medeiros, D. Jones, T. Smith, M. A. Rodriguez, P. McLaughlin, J. Romaguera, F. Cabanillas, and A. H. Sarris

Primary cutaneous non-Hodgkin’s lymphoma with aggressive histology: inferior outcome is associated with peripheral T-cell type and elevated lactate dehydrogenase, but not extent of cutaneous involvement
Ann Oncol 13: 1290-1299; doi:10.1093/annonc/mdf206
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Phase I and pharmacokinetics:

I. Sekine, N. Yamamoto, H. Kunitoh, Y. Ohe, T. Tamura, T. Kodama, and N. Saijo

Relationship between objective responses in phase I trials and potential efficacy of non-specific cytotoxic investigational new drugs
Ann Oncol 13: 1300-1306; doi:10.1093/annonc/mdf202
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Clinical trials:

H. E. M. van Luijn, A. W. Musschenga, R. B. Keus, W. M. Robinson, and N. K. Aaronson

Assessment of the risk/benefit ratio of phase II cancer clinical trials by Institutional Review Board (IRB) members
Ann Oncol 13: 1307-1313; doi:10.1093/annonc/mdf209
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Clinical case:

J.-M. Gornet, E. Savier, F. Lokiec, E. Cvitkovic, J. -L. Misset, and F. Goldwasser

Exacerbation of oxaliplatin neurosensory toxicity following surgery
Ann Oncol 13: 1315-1318; doi:10.1093/annonc/mdf254
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Letters to the Editor:

K. Wheatley and N. Ives

Adjuvant interferon for melanoma
Ann Oncol 13: 1319-1320; doi:NULL
[Extract] [FREE Full Text] [PDF] [Request Permissions]

C. J. A. Punt and A. M. M. Eggermont

Reply to "Adjuvant interferon for melanoma", by K. Wheatley & N. Ives
Ann Oncol 13: 1320; doi:10.1093/annonc/mdf297
[Extract] [FREE Full Text] [PDF] [Request Permissions]

S. Tanneberger, I. Malavasi, P. Mariano, F. Pannuti, and E. Strocchi

Planning palliative or terminal care: the dilemma of doctors’ prognoses in terminally ill cancer patients
Ann Oncol 13: 1320-1322; doi:10.1093/annonc/mdf223
[Extract] [FREE Full Text] [PDF] [Request Permissions]

D. Tassinari, M. Maltoni, and D. Amadori

Reply: Prediction of survival in terminally ill cancer patients: why we cannot avoid an evidence-based palliative medicine
Ann Oncol 13: 1322-1323; doi:NULL
[Extract] [FREE Full Text] [PDF] [Request Permissions]

Book reviews:

E. G. E. de Vries and P. H. B. Willemse

B.A. Chabner, D.L. Longo (eds.) Cancer Chemotherapy and Biotherapy: Principles and Practice
Ann Oncol 13: 1325; doi:10.1093/annonc/mdf237
[Extract] [FREE Full Text] [PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.